newsfilter
← Latest News
GlobeNewswire·

VBL Therapeutics Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

TEL AVIV, Israel and NEW YORK, Sept. 01, 2022 (GLOBE NEWSWIRE) -- VBL Therapeutics (NASDAQ:VBLT) ("VBL"), a biotechnology company developing targeted medicines for immune-inflammatory diseases, today announced that VBL received a written notification (